![Sample our Engineering & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5933/TOC-Subject-Sample-2021-Engineering-Tech.jpg"})
"Letter to the Editor: “Docetaxel and Its Nanoformulations: How Delivery Strategies Could Impact the Therapeutic Outcome?”." Therapeutic Delivery, 12(5), pp. 343–344
Financial & competing interests disclosure
MA Khan and N Joshi are employees of Intas Pharmaceuticals Ltd, India. I Ahmad is an employee of Jina Pharmaceuticals Inc., USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.